SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $996,668 | +25.1% | 215,729 | +118.7% | 0.01% | 0.0% |
| Q4 2022 | $796,987 | -41.2% | 98,637 | -40.1% | 0.01% | -12.5% |
| Q1 2022 | $1,355,000 | +12.3% | 164,790 | +103.1% | 0.01% | +33.3% |
| Q4 2021 | $1,207,000 | +14.7% | 81,129 | +45.6% | 0.01% | -14.3% |
| Q3 2021 | $1,052,000 | -35.8% | 55,709 | -36.8% | 0.01% | -30.0% |
| Q2 2021 | $1,639,000 | -47.6% | 88,169 | -35.8% | 0.01% | -52.4% |
| Q1 2021 | $3,125,000 | – | 137,303 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |